The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 04, 2021
Filed:
Oct. 20, 2017
Applicant:
Chiasma, Inc., Waltham, MA (US);
Inventor:
Gary Patou, Los Altos Hills, CA (US);
Assignee:
Chiasma, Inc., Needham, MA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61P 9/02 (2006.01); A61K 38/095 (2019.01); A61P 1/16 (2006.01); A61P 9/12 (2006.01); A61K 9/28 (2006.01); A61K 9/48 (2006.01); A61K 31/573 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
A61K 38/095 (2019.01); A61K 9/28 (2013.01); A61K 9/4891 (2013.01); A61K 31/573 (2013.01); A61K 45/06 (2013.01); A61P 1/16 (2018.01); A61P 9/02 (2018.01); A61P 9/12 (2018.01);
Abstract
Methods are disclosed of treating or preventing hypotension (e.g., neurogenic orthostatic hypotension or postprandial hypotension) or portal hypertension (e.g., bleeding esophageal varices associated with portal hypertension) or ascites (e.g., ascites associated with liver cirrhosis), by oral administration to affected subjects of compositions comprising a therapeutically effective amount of terlipressin or a pharmaceutically acceptable salt thereof.